Stem Cell Theranostics
Accelerating therapeutic discovery and enabling personalized medicine through the use of patient-derived cell models.
Launch date
Employees
Market cap
-
Enterprise valuation
$22—33m (Dealroom.co estimates Jan 2014.)
Redwood City California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$5.5m | Series A | ||
* | $150k | Grant | |
| Total Funding | $5.7m | ||
Related Content
Recent News about Stem Cell Theranostics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.